These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 14892062)
21. Effectiveness of synthetic water-soluble vitamin K preparations in bishydroxycoumarin-induced hypoprothrombinemia. OVERMAN RS; SORENSON CW; WRIGHT IS J Am Med Assoc; 1951 Feb; 145(6):393-9. PubMed ID: 14794454 [No Abstract] [Full Text] [Related]
22. Hypoprothrombinemia; effect of transfusions of blood fortified by administration of vitamin K to donors. BUTT HR; MAGATH TB; SELDON TH Arch Intern Med (Chic); 1948 Feb; 81(2):131-6. PubMed ID: 18871605 [No Abstract] [Full Text] [Related]
23. [Preventive effect of menaquinone-4 (K2) on hypoprothrombinemia caused by dicumarol]. Tajima T; Kawashima H; Kato Y; Ogo T; Miyao K Nihon Yakurigaku Zasshi; 1971 Jul; 67(4):419-30. PubMed ID: 4107009 [No Abstract] [Full Text] [Related]
24. Oral phytonadione in neonatal hypoprothrombinemia. SHOSHKES M; EPPLEBAUM A; WILNER M J Pediatr; 1959 Jul; 55(1):80-4. PubMed ID: 13665488 [No Abstract] [Full Text] [Related]
25. Intravenous emulsified vitamin K in the treatment of coumarin-induced hypoprothrombinemia. STRAGNELL R Am Heart J; 1952 Jul; 44(1):124-30. PubMed ID: 14933316 [No Abstract] [Full Text] [Related]
26. [Progress in management of dicumarol therapy; simplification of control; vitamin KI as antidote]. KOLLER F; LOELIGER A; FLUCKIGER P Helv Med Acta; 1952 Oct; 19(4-5):411-6. PubMed ID: 13021791 [No Abstract] [Full Text] [Related]
27. Hypoprothrombinemia due to dicumarol in a malingerer: a case report. STAFNE WA; MOE AE Ann Intern Med; 1951 Oct; 35(4):910-1. PubMed ID: 14878333 [No Abstract] [Full Text] [Related]
28. [Treatment and prevention of hemorrhage during dicumarol therapy, with special reference to the effect of amino acids on clotting]. SCHWENZER AW Geburtshilfe Frauenheilkd; 1951 Dec; 11(12):1089-1102. PubMed ID: 14926896 [No Abstract] [Full Text] [Related]
29. Vitamin K1 emulsions in bishydroxycoumarin emergencies; results of intravenous administration. VAN ITALLIE TB; STARE FJ J Am Med Assoc; 1951 Dec; 147(17):1652. PubMed ID: 14880420 [No Abstract] [Full Text] [Related]
30. Efficacy of water-soluble derivatives of vitamin K1 in counteracting drug-induced hypoprothrombinemia. MUSHETT CW; KELLEY KL; HIRSCHMANN R Blood; 1959 Jan; 14(1):37-49. PubMed ID: 13607577 [No Abstract] [Full Text] [Related]
31. Nutritional hypoprothrombinemia and metabolism of vitamin K. DOISY EA Fed Proc; 1961 Dec; 20():989-94. PubMed ID: 13886972 [No Abstract] [Full Text] [Related]
32. [A new study on the therapeutic action of vitamin K1 on hypoprothrombinemia in the premature infant]. VERGER P; LACHAUD Nourrisson; 1959; 47():221-6. PubMed ID: 13855226 [No Abstract] [Full Text] [Related]
33. Don't use the wrong vitamin K. Udall JA Calif Med; 1970 Apr; 112(4):65-7. PubMed ID: 4191061 [TBL] [Abstract][Full Text] [Related]
35. Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K. TOOHEY M Br Med J; 1952 Sep; 2(4786):687-90. PubMed ID: 12978288 [No Abstract] [Full Text] [Related]
36. Clinical consideration of vitamin K and hypoprothrombinemia. QUICK AJ Bull Chic Med Soc; 1949 Mar; 51(37):706-8. PubMed ID: 18124593 [No Abstract] [Full Text] [Related]
37. Hypoprothrombinemia in biliary fistula dogs induced by minute doses of dicumarol. FIELD JB Am J Physiol; 1952 Feb; 168(2):287-91. PubMed ID: 14903142 [No Abstract] [Full Text] [Related]
38. [The significance of hypoprothrombinemia in dentistry]. BEDNAR A; ERKES F Zahnarztl Welt; 1955 Feb; 10(3):79. PubMed ID: 14374650 [No Abstract] [Full Text] [Related]